Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone.
about
Fascin expression in CD30-positive cutaneous lymphoproliferative disordersT-cell variant of classical Hodgkin's lymphoma with nodal and cutaneous manifestations demonstrated by single-cell polymerase chain reactionEpstein-Barr virus-negative Hodgkin's lymphoma after mycosis fungoides: molecular evidence for distinct clonal origin.Hodgkin lymphoma: an update on its biology with new insights into classification.Retinoic acid receptor alpha drives cell cycle progression and is associated with increased sensitivity to retinoids in T-cell lymphoma.Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma.Rare expression of T-cell markers in classical Hodgkin's lymphoma.Hodgkin's lymphoma: the pathologist's viewpointt(8;9)(p22;p24)/PCM1-JAK2 activates SOCS2 and SOCS3 via STAT5.Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma.Loss of receptors for transforming growth factor beta in human T-cell malignancies.Cutaneous T cell lymphoma and classic Hodgkin lymphoma of the B cell type within a single lymph node: composite lymphomaNo evidence of HTLV-I proviral integration in lymphoproliferative disorders associated with cutaneous T-cell lymphomaDetection of clonal immunoglobulin gene rearrangements by polymerase chain reaction amplification and single-strand conformational polymorphism analysisComparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray.Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.A case of lymphomatoid papulosis occurred simultaneously with Ki-1-positive anaplastic large cell lymphoma.Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients.Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.Single-Fraction Radiotherapy for CD30(+) Lymphoproliferative Disorders.Pathobiology of CD30+ cutaneous T-cell lymphomas.Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid PapulosisComposite EBV negative peripheral T-cell lymphoma and diffuse large B-cell lymphoma involving the ileum: a case report and a systematic review of the literature.Breast implant-associated ALCL: a unique entity in the spectrum of CD30+ lymphoproliferative disorders.Clonal T-cell receptor β-chain gene rearrangements in differential diagnosis of lymphomatoid papulosis from skin metastasis of nodal anaplastic large-cell lymphoma.STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.Pathophysiological lessons from rare associations of immunological disorders.Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.Papular mycosis fungoides: report of two patients, literature review, and conceptual re-appraisal.Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?Lymphomatoid papulosis and human herpesviruses--A PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 related herpesviruses.Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas.The polymerase chain reaction. Applications in dermatology.Proteasome inhibition as a novel mechanism of the proapoptotic activity of γ-secretase inhibitor I in cutaneous T-cell lymphoma.Hodgkin's disease following mycosis fungoides: phenotypic and molecular evidence for different tumour cell clones.Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma.Identification of NPM-ALK interacting proteins by tandem mass spectrometry.Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma.Reed-Sternberg cells and the TNF family of receptors/ligands.
P2860
Q28213139-79044CA1-8B9F-4387-9BD3-201B1048F37DQ28221414-6FE742E3-5319-4A02-91B3-6C0BBC261F72Q30982800-A36243C8-A8C2-42FE-9ECB-0DD7D57EE314Q33588862-476DDD54-6FA9-4721-88B6-30BC2C91B28BQ33688613-2247D4D9-F41E-485A-9CCA-46E0DAFF5722Q34266303-513AFA58-3A4F-43B2-A7CA-C93004AA4D10Q34438875-118A11BD-853A-4227-99F1-799D8D50E23FQ34564836-97451FFE-A6F9-4A48-96E6-DFE5318FDF6AQ34570939-2ECA3489-FECA-4DC8-ABC3-215A2BDC83C4Q35022610-35364FBD-B01C-4CCC-A5C1-4C10AB3D9FBFQ35546848-BDEF954F-A18B-405C-8CBF-E286359D33D9Q35587448-BFF3D33D-2845-47A3-9FD8-916E8377C671Q35764698-29826F85-EF11-4B0E-8DF6-8D35F81BDE0CQ35833032-D237B9D7-51FE-4B6E-BE3C-7E4648367D3FQ35842022-34095EF3-EE72-4ADA-8A79-30DDB6E2D712Q35892550-E3D28B37-BEF8-48C5-B00A-DDE32D48FF6DQ35938576-0364E7F3-318C-40D1-957A-CD368996951DQ35987358-57FCDE8E-9EB1-45C3-B577-3617F3CED125Q36020985-AB6CDDF4-D868-4599-B6AB-B7EF6A9DE177Q36172858-65B48023-44AF-4F91-A776-DF37D218E4DAQ36367905-1C8454DD-24D8-4AC3-84A2-6CBE82DACA38Q36452258-FB0A4F26-D6EF-4988-8E63-5E4FBAC94DD6Q36637659-4C2784E5-5E93-4A60-9838-2B46D0A59FBFQ36714391-66780E88-D78D-437D-AF6C-600669B69393Q37070114-0E1ED2CB-268B-46A6-9627-2B5AD72CDB9CQ37075919-5CD95656-7AB8-49EE-8A20-8342FDF6E5F8Q37102356-D76EF7B3-9CA7-48CD-877F-5C2B87914C67Q37387679-7B0E1F50-1445-4B85-879F-1670799F0F27Q38104748-FFDAFE70-E174-4EF8-9ADD-86383F106DB1Q38218909-D395DC5F-F235-4716-8CDE-AF48017FA6D6Q38462639-7D9AC5D7-3E3C-4F63-8BC3-0F8ABEF7538DQ38471739-82C33FD3-8A5C-4022-825A-D3EA721FEC8AQ38707894-50650C90-8C81-4AA9-8074-1E812C08B28FQ39113034-1F4D8DB7-8B3F-4CE6-90BC-73AC0221A298Q39187805-5451846C-A7DE-48BD-A8CA-66D4B17FA7DFQ39589396-FF77C39C-34E6-4372-9653-3DBCEB259E39Q40239635-2F263817-BFC6-44DA-9B22-811D037C4332Q40589160-AC2D78AB-7FCC-4821-95E8-E3F223A7FA60Q40688204-222D51C4-2F8C-4AD2-99CE-E32C47E6B42CQ40875592-15CB570B-DC5D-4945-A4FA-65C336B816CF
P2860
Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Hodgkin's disease, lymphomatoi ...... ed from a common T-cell clone.
@en
type
label
Hodgkin's disease, lymphomatoi ...... ed from a common T-cell clone.
@en
prefLabel
Hodgkin's disease, lymphomatoi ...... ed from a common T-cell clone.
@en
P2093
P4510
P1476
Hodgkin's disease, lymphomatoi ...... ed from a common T-cell clone.
@en
P2093
P304
P356
10.1056/NEJM199204233261704
P407
P577
1992-04-01T00:00:00Z